Entecavir‐induced neutropenia in an adult living donor liver transplant recipient: Successful conversion to tenofovir alafenamide

At 22 weeks post‐transplantation for HBV‐related cirrhosis, an adult woman developed neutropenia which was aggravated by COVID‐19 (ANC 0.4 × 10(9)/L). Covid resolution and all “conventional” modifications were ineffective. Success within 2 weeks was achieved by switching entecavir to tenofovir alafe...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, I. Vern, Yurttaş, Nurgül Özgür, Ayer, Mesut, Poturoğlu, Şule, Kınacı, Erdem, Özden, İlgin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421973/
https://www.ncbi.nlm.nih.gov/pubmed/37575459
http://dx.doi.org/10.1002/ccr3.7741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421973/
https://www.ncbi.nlm.nih.gov/pubmed/37575459
http://dx.doi.org/10.1002/ccr3.7741

Ejemplares similares